| Issue |
Title |
File |
| Vol 21, No 1 (2025) |
Aspects of hypogonadism in oncological patients receiving antitumor treatment. Literature review |
(Rus)
|
|
Abramov M.E., Israelyan E.R., Tsareva A.S., Rumyantsev A.A., Firsov K.A., Matveev V.B.
|
| Vol 18, No 3 (2022) |
Molecular-genetic and cytogenetic characteristics of sporadic kidney cancer: literature review |
(Rus)
|
|
Popov S.V., Guseynov R.G., Skryabin O.N., Perepelitsa V.V., Davydov A.V., Barkhitdinov R.S., Katunin A.S., Mirzabekov M.M.
|
| Vol 18, No 1 (2022) |
Relationship of TP53 gene with retroelements in urogenital organs carcinogenesis |
(Rus)
|
|
Mustafin R.N.
|
| Vol 17, No 1 (2021) |
Urinary incontinence after radical prostatectomy: prognostic factors |
(Rus)
|
|
Aboyan I.A., Orlov Y.N., Shevchenko A.N., Pakus S.M., Hasigov A.V.
|
| Vol 17, No 1 (2021) |
Clinical and morphological features of non-muscle invasive bladder cancer: implications for treatment, prognosis and relapse of the disease (literature review) |
(Rus)
|
|
Pshikhachev A.M., Mikhaleva L.M., Gusniev M.A., Pechnikova V.V., Polyanko N.I., Sorokin N.I., Kamalov A.A.
|
| Vol 17, No 1 (2021) |
Modern aspects of targeted prostate biopsy |
(Rus)
|
|
Popov S.V., Orlov I.N., Malevich S.M., Sushina I.V., Grin’ E.A., Gulko A.M., Topuzov T.M., Vyazovtsev P.V., Chernysheva D.Y., Neradovskiy V.A.
|
| Vol 17, No 1 (2021) |
Past, present and future magnetic resonance diagnosis of prostate cancer |
(Rus)
|
|
Goncharuk D.A., Veliev E.I., Mikhaylov A.I.
|
| Vol 17, No 1 (2021) |
Atlantis exploration: predictive biomarkers to immunotherapy response |
(Rus)
|
|
Nosov A.K., Krotov N.F., Berkut M.V.
|
| Vol 16, No 4 (2020) |
Renin-angiotensin system: role in the development and progression of prostate cancer |
(Rus)
|
|
Chernogubova E.A., Kogan M.I.
|
| Vol 16, No 4 (2020) |
The role of microRNA in the diagnosis of prostate cancer |
(Rus)
|
|
Dolotkazin D.R., Shkurnikov M.Y., Alekseev B.Y.
|
| Vol 16, No 4 (2020) |
18F-FDG positron emission tomography combined with computed tomography in renal cell carcinoma diagnostics |
(Rus)
|
|
Ilyakov V.S., Pronin A., Mikhaylov A.I., Parnas A.V., Meshcheriakova N., Kamolova Z.H.
|
| Vol 16, No 4 (2020) |
Review of the article «18 F-FDG positron emission tomography combined with computed tomography in renal cell carcinoma diagnostics» |
(Rus)
|
|
Mukhortova O.V.
|
| Vol 16, No 4 (2020) |
Diferelin® as an effective chemical castration agent for patients with prostate cancer |
(Rus)
|
|
Nyushko K.M., Perepukhov V.M., Alekseev B.Y.
|
| Vol 16, No 4 (2020) |
International experience of using olaparib for metastatic castration-resistant prostate cancer: literature review |
(Rus)
|
|
Matveev V.B., Khalmurzaev O.A., Evsyukova O.I.
|
| Vol 16, No 4 (2020) |
Metastatic testicular and epididymal lesions in a patient with advanced prostate cancer: a case report and literature review |
(Rus)
|
|
Reva S.A., Lyublinskaya A.A., Prokhorov D.G., Pygamov K.G., Tyurin A.G., Sycheva А.M., Petrov S.B.
|
| Vol 16, No 3 (2020) |
Potential clinical application of free-circulating DNA from blood in renal cancer |
(Rus)
|
|
Yakubovich E.I., Polishchuk A.G., Evtushenko V.I.
|
| Vol 16, No 3 (2020) |
Current opportunities of therapy for patients with non-metastatic castration-resistant prostate cancer |
(Rus)
|
|
Alekseev B.Y., Nushko K.M., Kozlova P.S., Kaprin A.D., Mailyan O.I.
|
| Vol 16, No 3 (2020) |
High-intensity focused ultrasound (HIFU) in the treatment of localized prostate cancer. From total to focal ablation |
(Rus)
|
|
Aboyan I.A., Pakus S.M., Badyan K.I., Hasigov A.V., Galstyan A.M.
|
| Vol 16, No 3 (2020) |
Modern prostate cancer biomarkers. Prospects for EN2 in the prostate cancer diagnosis |
(Rus)
|
|
Tarabayeva A.S., Zhubanturliyeva A.B., Okhas I.M.
|
| Vol 16, No 2 (2020) |
Risk factors and methods for prevention of lymphogenic complications in oncourological operations in pelvic area (systematic review) |
(Rus)
|
|
Kotov S.V., Prostomolotov A.O., Guspanov R.I., Zhilov M.S.
|
| Vol 16, No 2 (2020) |
Robot-assisted radical cystectomy with urinary intestinal diversion (literature review) |
(Rus)
|
|
Gulie B.G., Bolokotov R.R.
|
| Vol 16, No 2 (2020) |
Late complications of the treatment of patients with germ cell tumors |
(Rus)
|
|
Danielyan D.G., Salimova A.A., Bulanov A.A., Fedyanin M.Y., Tryakin A.A.
|
| Vol 16, No 1 (2020) |
Molecular biomarkers in diagnosis of bladder cancer |
(Rus)
|
|
Shiryaev A.A., Govorov A.V., Vasieliev A.O., Okishev A.V., Kim Y.A., Fedina M.S., Bykov P.I., Pushkar D.Y.
|
| Vol 16, No 1 (2020) |
Molecular subtypes of bladder cancer and first success in personalized treatment |
(Rus)
|
|
Osetnik V.K., Mamizhev E.M., Dzalilov I.B., Artemyeva A.S., Kushnarev V.A.
|
| Vol 15, No 4 (2019) |
Renal cell carcinoma: what’s new in 2019 |
(Rus)
|
|
Evsyukova О.I., Matveev V.В.
|
| Vol 15, No 4 (2019) |
Bladder cancer: what’s new in 2018–2019 |
(Rus)
|
|
Karyakin О.В.
|
| Vol 15, No 3 (2019) |
Clinical and morphological features, immune profile of renal cell tumors with clear cytoplasm |
(Rus)
|
|
Osmanov Y.I., Kogan E.A., Severgina L.O., Rapoport L.M., Aleksandrov N.S., Tsarichenko D.G., Korolyov D.O.
|
| Vol 15, No 3 (2019) |
The role of the renin-angiotensin system in the appearance and progression of renal cell carcinoma: a literature review |
(Rus)
|
|
Kogan M.I., Akhokhov Z.M., Chernogubova E.A., Gusev A.A., Oitova Z.K.
|
| Vol 15, No 3 (2019) |
KIM-1 as a potential serological/urinological tumor-associated marker of renal cell carcinoma and chemotherapy nephrotoxicity |
(Rus)
|
|
Solokhina M.P., Sergeeva N.S., Marshutina N.V., Alentov I.I., Kanukoev K.Y., Nyushko K.M., Alekseev B.Y., Kaprin A.D.
|
| Vol 15, No 2 (2019) |
Neuroendocrine tumors of the urinary system: literature review |
(Rus)
|
|
Abbasova D.V., Polikarpova S.B., Kozlov N.A., Markova A.S., Bogush E.A., Kirsanov V.Y.
|
| Vol 15, No 2 (2019) |
Radium-223 systemic alpha-radiotherapy: targeted treatment of castration-resistant prostate cancer with bone metastases |
(Rus)
|
|
Volkova М.I., Olshanskaya A.S.
|
| Vol 15, No 1 (2019) |
Notch signaling pathway: dual role in tumour progression and therapeutic opportunities for bladder cancer |
(Rus)
|
|
Novikova M.V., Kopnin B.P., Kopnin P.B.
|
| Vol 15, No 1 (2019) |
The problem of choosing the tactics of managing patients with high and very high risk of prostate cancer: a review of the literature |
(Rus)
|
|
Buevich N.N., Protsenko S.A., Nosov A.K., Reva S.A., Artemyeva A.S., Berkut M.V.
|
| Vol 15, No 1 (2019) |
Changing paradigm of immunooncology in advanced kidney cancer: nivolumab and ipilimumab combination in the first line therapy |
(Rus)
|
|
Matveev V.B., Volkova M.I., Olshanskaya A.S.
|
| Vol 14, No 4 (2018) |
The role of molecular genetic alterations in sensitivity of the adjuvant intravesical therapy for non-muscle invasive bladder cancer |
(Rus)
|
|
Mikhaylenko D.S., Sergienko S.A., Zaborsky I.N., Saflullin K.N., Serebryany S.A., Safronova N.Y., Nemtsova M.V., Kaprin A.D., Alekseev B.Y.
|
| Vol 14, No 4 (2018) |
Metastatic hormone-sensitive prostate cancer: Practical guidelines and optimization of therapy selection |
(Rus)
|
|
Gafanov R.A., Dzidzaria A.G., Kravtsov I.B., Fastovets S.V.
|
| Vol 14, No 3 (2018) |
SEQUENTIAL THERAPY OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: NEW POSSIBILITIES |
(Rus)
|
|
Markova A.S., Matveev V.B., Nazranov B.M.
|
| Vol 14, No 3 (2018) |
MOLECULAR EPIDEMIOLOGY OF RENAL CANCER |
(Rus)
|
|
Zaridze D.G., Mukeriya A.F., Shan’gina O.V., Matveev V.B.
|
| Vol 14, No 2 (2018) |
Comparison of the EORTC and CUETO prognostic models in non-muscle-invasive bladder cancer |
(Rus)
|
|
Kaprin A.D., Apolikhin O.I., Alekseev B.Y., Roshchin D.A., Kachmazov A.A., Perepechin D.V., Golovashchenko M.P., Deryagina D.M.
|
| Vol 14, No 1 (2018) |
Bladder cancer and the use of the fast track method in the early rehabilitation of oncological patients (literature review) |
(Rus)
|
|
Voroshin D.G., Vazhenin A.V., Khoronenko V.E., Karnaukh P.A.
|
| Vol 14, No 1 (2018) |
Bladder cancer: what’s new in 2017 |
(Rus)
|
|
Karyakin O.B., Kaprin A.D.
|
| Vol 14, No 1 (2018) |
On staging of urologic cancers in accordance with the updated 8th edition of the TNM Classification |
(Rus)
|
|
Kirichek A.A., Kamolov B.S., Savyolov N.A., Matveev V.B.
|
| Vol 13, No 4 (2017) |
Prognostic and predictive biomarkers of prostate cancer |
(Rus)
|
|
Rakul S.A., Kamilova T.A., Golota A.S., Shcherbak S.G.
|
| Vol 13, No 3 (2017) |
Is there an association between prostate cancer and human papillomaviruses? Returning to the unresolved problem |
(Rus)
|
|
Volgareva G.M.
|
| Vol 13, No 3 (2017) |
Possibilities of optimization of the second line targeted therapy for metastatic renal cell carcinoma |
(Rus)
|
|
Markova A.S., Matveev V.B.
|
| Vol 13, No 3 (2017) |
Radium-223 in treatment of castration-resistant prostate cancer with skeletal metastases |
(Rus)
|
|
Matveev V.B., Markova A.S.
|
| Vol 13, No 2 (2017) |
Melanoma of the penis and urethra: literature review and observations from clinical practice |
(Rus)
|
|
Nosov A.K., Petrov S.B., Gafton G.I., Protsenko S.A., Myasnyankin M.Y., Vorob’ev A.V., Mamizhev E.M., Dzhalilov I.B., Khashirov K.A.
|
| Vol 13, No 2 (2017) |
Risk factors and correction methods for postoperative vesicourethral anastomotic strictures: literature review |
(Rus)
|
|
Reva I.A., Zhivov A.V., Bernikov A.N., Pushkar’ D.Y.
|
| Vol 13, No 1 (2017) |
Role and significance of multiparametric magnetic resonance imaging in prostate cancer diagnostics |
(Rus)
|
|
Kossov P.A., Chernyaev V.A., Akhverdieva G.I., Kamolov B.S., Abdullin I.I., Panov V.O., Buydenok Y.V., Matveev V.B., Turin I.E.
|
| Vol 12, No 1 (2016) |
Clinical economic assessment of the use of pazopanib in the therapy of disseminated kidney cancer |
(Rus)
(Eng)
|
|
Zyryanov S.K., Frolov M.Y., Dyakov I.N.
|
| Vol 11, No 3 (2015) |
Chemotherapy in the treatment of metastatic prostate cancer: the present state of the problem |
(Rus)
|
|
Alekseev B.Y.
|
| Vol 11, No 1 (2015) |
Noninterventional studies of depot formulations of LHRH analogues for prostate cancer in routine clinical practice. The launch of an observational program to assess the use of Eligard 45 mg in Russia |
(Rus)
|
|
Matveev V.B., Markova A.S.
|
| Vol 11, No 1 (2015) |
Sorafenib is the first targeted agent to treat metastatic kidney cancer |
(Rus)
|
|
Matveev V.B., Chernyaev V.A.
|
| Vol 10, No 4 (2014) |
Diagnostic value of [-2]proPSA and PHI index (review of literature) |
(Rus)
|
|
Sidorenkov A.V., Govorov A.V., Sadchenko A.V., Pushkar D.Y.
|
| Vol 10, No 3 (2014) |
Axitinib in the successive targeted therapy of patients with metastatic kidney cancer |
(Rus)
|
|
Alekseev B.Y., Kalpinsky A.S., Nyushko K.M., Kaprin A.D.
|
| Vol 10, No 2 (2014) |
PCA3 IS A TRUE ONCOMARKER OF PROSTATE CANCER: A REVIEW OF LITERATURE |
(Rus)
|
|
Sidorenkov A.V., Pushkar D.Y.
|
| Vol 10, No 1 (2014) |
INTERMITTENT HORMONE THERAPY WITH ELIGARD IN PATIENTS WITH PROSTATE CANCER |
(Rus)
|
|
Alekseev B.Y., Krasheninnikov A.A., Nyushko K.M., Kalpinsky A.S., Kaprin A.D.
|
| Vol 10, No 1 (2014) |
ANDROGEN DEPRIVATION THERAPY WITH LUTEINIZING HORMONE-RELEASING HORMONE ANTAGONISTS FOR PROSTATE CANCER: BEST DISEASE CONTROL WITH A LOWER RISK OF SIDE EFFECTS. RESULTS OF ANALYSIS OF 6 COMPARATIVE RANDOMIZED PHASE III TRIALS OF DEGARELIX AND LUTEINIZIN |
(Rus)
|
|
Markova A.S., Matveev V.B.
|
| Vol 9, No 4 (2013) |
PERI-OPERATIVE CHEMOTHERAPY IN MUSCLE INVASIVE BLADDER CANCER: OVERVIEW AND A RATIONALE FOR THE NEED TO SEEK ALTERNATIVE TREATMENT: MAGNOLIA CLINICAL TRIAL |
(Rus)
|
|
Korneyev I.A., Aboyan I.A., Alekseev B.Y., Apolikhin O.I., Komyakov B.K., Matveev V.B., Colombel M., Heidenreich A., Martínez-Piñeiro L., Babjuk M., Surcel C., Yakovlev P., Colombo R., Radziszewski P., Witjes F., Mulders P., Schipper R., Witjes W.
|
| Vol 9, No 3 (2013) |
SATURATION BIOPSY OF THE PROSTATE (REVIEW) |
(Rus)
|
|
Sadchenko A.V., Govorov A.V., Pushkar D.Y., Vasiliev A.O.
|
| Vol 9, No 3 (2013) |
ПРИМЕНЕНИЕ 1-, 3- И 6-МЕСЯЧНЫХ ЛЕКАРСТВЕННЫХ ДЕПО-ФОРМ ЛЕЙПРОРЕЛИНА АЦЕТАТА В ГОРМОНАЛЬНОЙ ТЕРАПИИ РАКА ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ В 9 ЕВРОПЕЙСКИХ СТРАНАХ: ОБЗОР ДОКАЗАТЕЛЬСТВ И ЭКОНОМИЧЕСКАЯ ОЦЕНКА |
(Rus)
|
|
Wex J., Sidhu M., Odeyemi I., Abou-Setta A., Retsa P., Tombal B.
|
| Vol 9, No 2 (2013) |
CURRENT POSSIBILITIES OF DRUG THERAPY FOR CASTRATION-RESISTANT PROSTATE CANCER |
(Rus)
|
|
Markova A.S.
|
| Vol 9, No 1 (2013) |
THE POSSIBILITIES AND MECHANISMS OF ACTION OF HORMONE THERAPY FOR CASTRATION-RESISTANT PROSTATE CANCER |
(Rus)
|
|
Alekseev B.Y., Andrianov A.N.
|
| Vol 8, No 1 (2012) |
THE DIFFERENTIATIVE DIAGNOSIS OF RENAL CYSTS |
(Rus)
|
|
Seregin A.V., Borzetsovskaya V.V.
|
| Vol 8, No 1 (2012) |
METHODS FOR IDENTIFICATION OF THE ELEMENTS OF THE PROSTATE NEUROVASCULAR BUNDLE (A REVIEW OF LITERATURE) |
(Rus)
|
|
Ledyaev D.S., Zagainova E.V., Atduyev V.A.
|
| Vol 7, No 4 (2011) |
THE STATE-OF-THE-ART OF PROTEOMIC STUDIES OF MARKERS FOR KIDNEY CANCER (A REVIEW OF LITERATURE) |
(Rus)
|
|
Kovalev S.V., Shevchenko V.E.
|
| Vol 7, No 4 (2011) |
POSSIBILITIES OF USING THE FLUORESCENCE IN SITU HYBRIDIZATION TECHNIQUE IN THE DIAGNOSIS OF BLADDER CANCER AND ITS RECURRENCES |
(Rus)
|
|
Matveev V.B., Karseladze A.I., Kazaryan A.P., Khachaturyan A.V., Kamolov B.S., Gigiadze O.V., Kalinin S.A.
|
| Vol 7, No 3 (2011) |
INTRAVESICAL THERAPY FOR BLADDER CANCER: STATE-OF-THE ART |
(Rus)
|
|
Protoshchak V.V., Kukushkin A.V., Babkin P.A., Shestayev A.Y., Kubin N.D., Shpilenya E.S., Novikov A.I.
|
| Vol 7, No 3 (2011) |
TADALAFIL IN THE TREATMENT OF ERECTILE DYSFUNCTION FOLLOWING RADICAL PROSTATECTOMY: A REVIEW |
(Rus)
|
|
Govorov A.V., Pushkar D.Y.
|
| Vol 7, No 2 (2011) |
PROSTATE CRYOABLATION |
(Rus)
|
|
Govorov A.V., Pushkar D.Y., Ivanov V.Y.
|
| Vol 7, No 1 (2011) |
CURRENT APPROACHES TO TREATING HORMONE REFRACTORY PROSTATE CANCER |
(Rus)
|
|
Karyakin O.B.
|
| Vol 6, No 3 (2010) |
TREATMENT IN PATIENTS WITH MUSCLE NONINVASIVE CARCINOMA OF THE URINARY BLADDER AFTER UNSUCCESSFUL INTRAVESICULAR BCG THERAPY |
(Rus)
|
|
Figurin K.M.
|
| Vol 6, No 3 (2010) |
NEW METHODS FOR PREDICTING THE SENSITIVITY OF RENAL CANCER TO IMMUNOTHERAPY ON THE BASIS OF ANALYSIS OF MOLECULAR GENETIC CHARACTERISTICS OF A TUMOR |
(Rus)
|
|
Aivazov M.T., Bozhenko V.K., Kaprin A.D.
|
| Vol 6, No 2 (2010) |
HYPERBARIC OXYGENATION IN THE TREATMENT OF LATE POSTRADIATION CYSTITIS |
(Rus)
|
|
Loran O.B., Sinyakova L.A., Mitrokhin A.A., Plesovsky A.M.
|
| Vol 6, No 2 (2010) |
INTERNAL DRAINAGE OF THE UPPER URINARY TRACT IN URETERAL TUMOR OBSTRUCTIONS: A REVIEW OF LITERATURE |
(Rus)
|
|
Komyakov B.K., Guliyev B.G.
|
| Vol 6, No 2 (2010) |
CURRENT TREATMENTS FOR UROTHELIAL CANCER OF THE UPPER URINARY TRACT |
(Rus)
|
|
Afonin S.V., Volkova M.I., Matveev V.B.
|
| Vol 6, No 1 (2010) |
РОЛЬ ВЫПОЛНЕНИЯ ПОВТОРНОЙ ТРАНСУРЕТРАЛЬНОЙ РЕЗЕКЦИИ В ЛЕЧЕНИИ БОЛЬНЫХ РАКОМ МОЧЕВОГО ПУЗЫРЯ БЕЗ МЫШЕЧНОЙ ИНВАЗИИ |
(Rus)
|
|
Rolevich A.I., Sukonko O.G., Krasny S.A., Strotsky A.V.
|
| Vol 6, No 1 (2010) |
ADJUVANT RADIOTHERAPY AFTER RADICAL PROSTATECTOMY |
(Rus)
|
|
Karyakin O.В.
|
| Vol 6, No 1 (2010) |
CURRENT VIEWS OF THE GLEASON GRADING SYSTEM |
(Rus)
|
|
Gorban N.A., Kudaibergenova A.G.
|
| Vol 5, No 4 (2009) |
РОЛЬ БЕВАЦИЗУМАБА В ЛЕЧЕНИИ МЕТАСТАТИЧЕСКОГО ПОЧЕЧНО-КЛЕТОЧНОГО РАКА |
(Rus)
|
|
., ., ., .
|
| Vol 5, No 3 (2009) |
ЭФФЕКТИВНОСТЬ СУНИТИНИБА В ТАРГЕТНОЙ ТЕРАПИИ МЕТАСТАТИЧЕСКОГО РАКА ПОЧКИ |
(Rus)
|
|
., .
|
| Vol 5, No 2 (2009) |
ПРОГНОСТИЧЕСКИЕ МОЛЕКУЛЯРНО-ГЕНЕТИЧЕСКИЕ МАРКЕРЫ РАКА МОЧЕВОГО ПУЗЫРЯ (ОБЗОР ЛИТЕРАТУРЫ) |
(Rus)
|
|
., ., ., .
|
| Vol 5, No 1 (2009) |
РЕТЕНЦИОННЫЕ ОСЛОЖНЕНИЯ СО СТОРОНЫ ВЕРХНИХ МОЧЕВЫХ ПУТЕЙ У БОЛЬНЫХ РАКОМ ШЕЙКИ МАТКИ IIB—III СТАДИИ |
(Rus)
|
|
., ., ., ., .
|
| Vol 4, No 4 (2008) |
Angiogenic factors in renal cell carcinoma |
(Rus)
|
|
Trapeznikova M.F., Glybin P.A., Morozov A.P., Kylychbekov M.B., Kushlinskiy N.Y.
|
| Vol 4, No 3 (2008) |
Review of materials of 23rd annual congress of European Association of Urologists |
(Rus)
|
|
Volkova I.M.
|
| Vol 4, No 2 (2008) |
Drug prophylaxis of the prostate cancer. Long term results analysis |
(Rus)
|
|
Pushkar D.U., Rasner P.I.
|
| Vol 4, No 1 (2008) |
Incidental prostate cancer |
(Rus)
|
|
Marisov L.V., Vinarov A.Z.
|
| Vol 3, No 4 (2007) |
Brachytherapy using steady sources for prostate cancer |
(Rus)
|
|
Petrovsky A.V., Nechushkin M.I., Bukharkin B.V.
|
| Vol 3, No 4 (2007) |
Bilateral nephroblastoma in children |
(Rus)
|
|
Shvetsova M.V., Sharoyev T.A.
|
| Vol 3, No 1 (2007) |
Radical surgery for invasive bladder carcinoma |
(Rus)
|
|
Krasnyi S.A.
|
| Vol 2, No 4 (2006) |
Thermodestruction methods in the treatment of renal-cell carcinoma |
(Rus)
|
|
Prokhorov D.G., Karelin M.I., Shkolnik M.I., Krotova O.A.
|
| Vol 2, No 3 (2006) |
Clinical value of chromosomal genetic changes in urothelial cells in urinary bladder cancer |
(Rus)
|
|
Bashkatov S.V., Nemtsova M.V., Karyakin O.B.
|
| Vol 2, No 3 (2006) |
Intravesicular chemotherapy in patients with superficial bladder cancer: possibilities of efficiency enhancement and prospects |
(Rus)
|
|
Figurin K.M.
|
| Vol 2, No 1 (2006) |
Radionuclide therapy in the treatment of patients with prostatic cancer with metastases in the bones |
(Rus)
|
|
Krylov V.V., Karyakin O.B., Drozdovsky B.Y.
|
| 1 - 94 of 94 Items |
|
